Clinical Trial

Corticosteroid Against Saline Injections for Thumb Osteoarthritis (CASITOA)

Study acronym: CASITOA
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Thumb osteoarthritis or trapeziometacarpal osteoarthritis (TMO) is a common and painful form of hand arthritis that limits thumb mobility and hand function, affecting patients' quality of life. Although corticosteroids injections are a typical treatment, their effectiveness has been challenged, and side effects have been reported. Recent studies suggest that saline injections, usually considered inactive, might be a viable treatment option. The primary goal of this study is to compare the effectiveness of saline injections versus corticosteroids injections in reducing TMO-related pain and improving hand function. In this study, 40 people with TMO will be randomly assigned to receive either a corticosteroids or a saline injection, without them or the doctors performing the injection knowing which one was administered (double blind). If saline injections prove more effective, they could provide a less harmful and cheaper therapeutic alternative for TMO patients.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-05-02; most recent amendment 2026-01-20.
Status change: Not Yet Recruiting → Recruiting 2025-11-23
Trial Details
NCT Number NCT06401317
Lead Sponsor Université du Québec à Trois-Rivières
Collaborators: Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal, McGill University, Université de Montréal, Centre hospitalier de l'Université de Montréal (CHUM), Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Conditions Trapeziometacarpal Osteoarthritis
Enrollment 40 participants
Start Date 2025-11-04
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-22